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RESUMEN
Se describe una estrategia sintética sencilla para la sínte-
sis de las hasta ahora no descritas 5-arilazo-1,3-difenil-
6-substituido-1H-pirazole[3,4-d ]pirimido[1,6-b][1,2,4]tria-
zinas 5a-n. Los datos de los espectros indican que los
compuestos estudiados existen predominantemente en
la forma tautomérica hidrazona 5A. Se discute la selec-
tividad y el mecanismo de las reacciones estudiadas.
Palabras clave: Haluros de hidrazonoílo. Tautomería azo-
hidrazona. Heterociclos.
SUMMARY
A simple synthetic strategy is described for synthesis of
the hitherto unreported 5-arylazo-1,3-diphenyl-6-substi-
tuted-1H-pyrazolo[3,4-d]pyrimido[1,6-b][1,2,4]triazines
5a-n. The spectral data indicated that the studied com-
pounds exist predominantly in the hydrazone tautomer-
ic form 5A. The site-selectivity and mechanism of the
studied reactions are discussed.
Key words: Hydrazonoyl halides. Azo-hydrazone tau-
tomerism. Heterocycles.
RESUM
Es descriu una estratègia sintètica senzilla per a la sín-
tesi de les fins ara no descrites 5-arilazo-1,3-difenil-6-
substituït-1H-pirazole[3,4-d]pirimido[1,6-b][1,2,4]triazi-
nes 5a-n. Les dades dels espectres indiquen que els
compostos estudiats existeixen predominantment en la
forma tautomèrica hidrazona 5A. Es discuteix la selec-
tivitat i el mecanisme de les reaccions estudiades.
Mots clau: Halurs d’hidrazonoïl. Tautomeria azo-hidra-
zona. Heterocicles.
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INTRODUCTION
Arylazo heterocycles are known to be useful in the field of
material sciences and theoretical chemistry(1-7). In addition
to these applications, azo compounds are used as photo-
sensitive species in photographic or electrophotographic
systems and are the dominant organic photoconductive
materials in commercial copiers(8). To the best of our knowl-
edge reactions of 5-amino-4,5-dihydro-1,3-diphenyl-4-imi-
no-1H-pyrazolo[3,4-d]pyrimidine 1 with hydrazonoyl halides
have not been reported hitherto since we have reported its
preparation in 1994(9). In continuation of our previous stud-
ies in chemistry of hydrazonoyl halides(10-17) and azo-hydra-
zone tautomerism of arylazo heterocycles(1-7), we wish to
report here in a convenient synthesis of the title compounds
via reactions of 1 with various hydrazonoyl halides 2 and
elucidation of their tautomeric form. 
RESULTS AND DISCUSSION
5-Amino-4,5-dihydro-1,3-diphenyl-4-imino-1H-pyrazolo[3,4-
d]pyrimidine 1(9) and the hydrazonoyl halides 2(18) were pre-
pared by literature methods. Reaction of 1 with each of the
hydrazonoyl halides 2 in refluxing ethanol in the presence
of triethylamine gave in each case one isolable product as
evidenced by tlc analysis of the crude product. This find-
ing indicates that the studied reaction is site- and regios-
elective. This is because the studied reaction can theoret-
ically proceed through either one of the two routes A or B
depicted in Scheme 1, leading thus to the formation of
either 5 and/ or 6. On the basis of elemental analyses and
IR, 1H NMR and UV spectra (see Experimental), the isolat-
ed products were assigned structure 5 rather than the iso-
meric structure 6. For example, their IR spectra revealed
in each case a hydrazone NH absorption band in the region
3309 – 3474 cm–1. In addition their 1H NMR spectra are
charaterized by a singlet signal assignable to the hydra-
zone NH proton at δ 10.16 – 10.80. 
The assigned structure 5 was further confirmed by an
alternate synthesis of the product 5a as a typical example
of the series prepared. Thus, treatment of 1 with phenacyl
bromide in refluxing pyridine gave 9 (Scheme 2). Coupling
of the latter with benzenediazonium chloride in ethanol in
the presence of sodium hydroxide yielded the product 5a
that proved identical in all respects (m.p., mixed m.p., IR,
1H NMR and UV) with that one obtained above from the
reaction of 1 with 2a (Scheme 1).
On the basis of the foregoing evidence, it is not unrea-
sonable to suggest that the studied reaction of 1 with 2 is
regio- and site-selective. This selectivity seems to be  due
to the fact that the imino nitrogen is more nucleophilic than
the amino group. Thus, it is not unreasonable to suggest
that the studied reaction starts with the initial nucleophilic
attack of the imino nitrogen at the hydrazonoyl halide to
give the amidrazone 3 rather than its isomer 4 (Scheme 1).
The intermediate 3 underwent in situ dehydrative cycliza-
tion under the employed reaction conditions to give 5 as
end product. This rationalization is also consistent with lit-
erature data. For example, lit-
erature reports indicate that
reactions of heterocycles hav-
ing N-amino-C-imino group
with halo ketones, acyl
halides and halo esters pro-
ceed via nucleophilic dis-
placement of the halogen by
the imino group followed by
condesation of the amino
group with the carbonyl group
leading thus to the formation
of fused 3-substituted-1,2,4-
triazole derivative(19).
Finally, as shown in Scheme
1, the products 5 can have
two tautomeric forms name-
ly the hydrazone form 5A and
the azo tautomeric form 5B.
Of these two forms, the tau-
tomeric form 5A seems to be
the form of choice for the
studied compounds as it is
consistent with their elec-
tronic absorption spectra and
1H NMR spectra. For exam-
ple, like typical hydrazones(20,
21) the electronic absorption
spectra of 5 in dioxane
revealed, in each case two
characteristic absorption
bands in the regions 378–350
and 295–249 nm (Table 1) and
the spectra of compound 5h,
taken as a typical example of
the series prepared, in differ-
ent solvents exhibit little, if
there is any, solvent depen-
dence (Table 1). On the basis
of such absorption pattern, it



























































Route B Route A
X = Cl or Br 
Ar = C6H4Y
f, Me / 4-Me; g, Me / 4-Cl; h, Me / H; i, Me / 4-Cl; j, Me / 3-Cl; 
k, Me / 3-NO2; l, Me / 4-NO2; m, Me / 4-Ac; n, Me / 4-EtOCO
R/Y: a, Ph / H; b, Ph / 4-Cl; c, 2-thienyl / H; d, 2-thienyl / 4-Cl; e, Me / 4-MeO;  
Scheme 1.
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studied compounds 5 exist in
solution in one tautomeric
form namely 5A. This con-
clusion was also confirmed
by their 1H NMR spectra. Thus
whereas the latter spectra
showed a hydrazone NH pro-
ton signal in the region δ
10.16–10.60 (see Experimen-
tal), they revealed the abs-
ence of signal near δ 11.69
characteristic for the NH of
the azo-enamine form 5B(22).
EXPERIMENTAL
Melting points are uncorrect-
ed. IR spectra were recorded
(KBr) on Pye Unicam SP-1000
Spectrophotometer. 1H NMR
spectra were obtained on
Varian Gemini 200 MHz spec-
trometer using TMS as inter-
nal reference. Chemical shifts
are expressed as δ. Mass
spectra were recorded on a
GCMS-QP 1000 EX mass
spectrometer operating at
70 eV.
The elemental analyses were
performed at the Micro-
analytical Center at Cairo








1 with hydrazonoyl halides.
General method - To a mixture of 5-amino-
1,3-diphenyl-4-imino-4,5-dihydro-1H-pyra-
zolo[3,4-d]pyrimidine 1 (1.56 g, 5 mmole) and
the appropriate hydrazonoyl halide 2
(5 mmole) in ethanol (40 ml), triethyl amine
was added (0.7 ml, 5 mmole). The mixture
was refluxed for 5 h, then left to cool to room
temperature. The solid product that precip-
itated, was filtred off, dried and crystallized
from ethanol/DMF to give the respective
product 5. The physical constants of  the
compounds prepared 5a-n are listed below.
5-Phenylazo-1,3,6-triphenyl-1H-pyrazolo[3,4-
d]pyrimido[1,6-b][1,2,4]triazine (5a) Orange
solid (2.28 g, 90 %), mp 210ºC. IR (cm–1): 3316,
1HNMR (DMSO-d6) 7.02-8.20 (m, 20H, ArH),
8.22 (s, 1H, ArH), 9.96 (s, 1H, NH). Ms m/z (%)
508 (M+ +2, 4), 507 (M+ +1, 3), 506 (M+, 6), 416
(17), 389 (14), 387 (18), 286 (13), 105 (79), 104 (17), 77 (100).
Anal. calcd. for C31H22N8 (506.57) C, 73.52, H 4.35, N 22.13.
Found: C 73.45, H 4.34, N 22.46 %.
5-(4-Chlorophenylazo)-1,3,6-triphenyl-1H-pyrazolo[3,4-
d]pyrimido-[1,6-b][1,2,4]triazine (5b) Orange solid (2.40 g,
89 %), mp 220ºC. IR (cm–1): 3309,1HNMR (DMSO-d6) 6.99-
8.09 (m, 15H, ArH), 8.17 (s, 1H, ArH), 8.46 (d, J = 9Hz, 2H,
ArH), 8.82 (d, J = 9Hz, 2H, ArH), 9.96 (s, 1H, NH). Ms m/z
(%) 542 (M+ +2, 6), 541 (M+ +1, 5), 540 (M+, 7), 416 (36), 387
(18), 287 (18), 286 (11), 111 (5), 105 (78), 77 (100). Anal. cal-
cd. for C31H21ClN8 (541.01) C, 68.83, H 3.89, N 20.72.  Found:
C 68.67, H 3.80, N 20.82%
5-Phenylazo-1,3-diphenyl-6-thienyl-1H-pyrazolo[3,4-
d]pyrimido[1,6-b][1,2,4]triazine (5c) Orange solid (2.3 g,
90 %), mp 200ºC. IR (cm–1): 3472, 1H NMR (CDCl3) 7.01-8.29
and 8.35-8.85 (m, 18H, ArH), 8.31 (s, 1H, ArH), 10.08 (s, 1H,
NH). Ms m/z (%) 513 (M+ +1, 1), 512 (M+, 1), 422 (47), 362
(11), 287 (29), 127 (8), 111 (100), 91(4), 77(41). Anal. calcd.
TABLE I
The characteristic electronic absorption spectra of Compounds 5a-n
in dioxane.
Compd. λ (log ε) Compd. λ (log ε)
No. No.
5a 381.3(3.76), 284.7 (3.72) 5h* 365.6(3.37),256.2 (3.54)0
5b 379.4(4.27), 291.4 (4.17) 5i 368.8(3.24),253.2 (3.36)0
5c 339.8(4.16), 257.6 (4.45) 5j 364.8 (3.19), 252.0 (3.36)
5d 364.4(3.59), 268.6 (3.70) 5k 374.0 (3.35), 250.0 (3.23)
5e 373.0 (3.21),253.0 (3.33) 5l 374.8 (3.21), 251.8 (3.55)
5f 365.0 (3.19),248.6 (3.38) 5m 378.0 (3.37), 295.2 (3.28)
5g 365.8 (3.19),253.0 (3.47) 5n 349.8 (3.25), 263.8 (3.40)
*Compound 5h in different solvents: Solvent, λ (log ε): Ethanol, 326.0 (3.33),
260.2 (3.63); Acetone, 342.8 (3.38), 259.6 (3.69)  
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for C29H20N8S (512.59) C, 67.96,  H 3.91, N 21.88. Found: C
67.72, H 3.71, N 21.86 %.
5-(4-Chlorophenylazo)-1,3-diphenyl-6-thienyl-1H-pyrazo-
lo[3,4-d]pyrimido[1,6-b][1,2,4]triazine (5d) Orange solid
(2.50 g, 92 %), mp 235ºC. IR (cm–1): 3474, 1H NMR (CDCl3)
7.16-7.83 (m, 13H, ArH), 8.01 (d, J = 8Hz, 2H, ArH), 8.12 (d,
J = 8 Hz, 2H, ArH), 8.31 (s, 1H, ArH), 10.06 (s, 1H, NH). Ms
m/z (%) 549 (M+ +2, 2), 548 (M+ +1), 422 (25), 279 (3), 140
(2), 111 (100), 78 (7). Anal. calcd. for C29H19ClN8S (547.03) C,
63.68, H 3.48, N 20.49.  Found: C 63.90, H 3.32, N 20.49 %.
6-Methyl-5-(4-methoxyphenylazo)-1,3-diphenyl-1H-pyra-
zolo[3,4-d]pyrimido[1,6-b][1,2,4]triazine (5e) Dark orange
solid (1.8 g, 78 %), mp > 340ºC. IR (cm–1): 3349, 1HNMR
(DMSO-d6) 2.39 (s, 3H, CH3), 3.80 (s, 3H, OCH3), 7.37-7.72
and 8.03-8.27 (m, 10H, ArH), 7.94 (s,1H, ArH), 8.37 (d, J =
8 Hz, 2H, ArH), 8.80 (d, J = 8 Hz, 2H, ArH), 10.20 (s, 1H, NH).
Ms m/z (%) 476 (M+ +2, 5), 475 (M+ +1, 33), 474 (M+, 100),
459 (52), 141 (11), 121 (22), 95 (21), 92 (10), 77 (52). Anal.
calcd. for C27H22N8O (474.52) C, 68.35, H 4.64, N 23.62.
Found: C 68.17, H 4.82, N 23.93 %.
6-Methyl-5-(4-methylphenylazo)-1,3-diphenyl-1H-pyrazo-
lo[3,4-d] pyrimido[1,6-b][1,2,4]triazine (5f): Orange solid
(1.83 g, 80 %), m.p 265ºC. IR (cm–1): 3446. 1H NMR (CDCl3)
2.18 (s, 3H, CH3), 2.53 (s, 3H, CH3), 6.84-7.52 (m, 10H, ArH),
7.73 (d, J = 9 Hz, 2H, ArH, 8.30 (d, J = 9 Hz, 2H, ArH), 8.42
(s, 1H, ArH), 10.30 (s, 1H, NH). Ms m/z (%) 460 (M+ +2, 6),
459 (M+ +1, 33), 458 (M+, 100), 354 (21), 287 (47), 129 (15),
111 (21), 104 (15), 91 (34), 77 (74). Anal. calcd. for C27H22N8
(458.52) C, 70.74, H 4.80, N 24.45. Found: C 70.59, H 4.94,
N 24.22 %.
6-Methyl-5-(3-methylphenylazo)-1,3-diphenyl-1H-pyrazo-
lo[3,4-d]pyrimido[1,6-b][1,2,4]triazine (5g) Dark yellow sol-
id (1.9 g, 83 %), mp > 340ºC. IR (cm–1): 3350, 1H NMR (DMSO-
d6) 2.50 (s, 3H, CH3), 2.66 (s, 3H, CH3), 7.43-8.84 (m, 14H,
ArH), 8.0 (s, 1H, ArH), 10.16 (s, 1H, NH). Ms m/z (%) 459 (M+
+1, 8), 458 (M+, 24), 354 (45), 326 (30), 286 (38), 153 (11),
106 (20), 91 (47), 83 (32), 77 (100). Anal. calcd. for C27H22N8
(458.52) C, 70.74, H 4.80, N 24.45. Found: C 70.57, H 4.54,
N 24.8 %.
6-Methyl-5-phenylazo-1,3-diphenyl-1H-pyrazolo[3,4-
d]pyrimido[1,6-b][1,2,4]triazine (5h) Yellow solid (1.8 g,
81 %), mp > 340ºC. IR (cm–1): 3423, 1H NMR (DMSO-d6) 2.71
(s, 3H, CH3), 7.43-8.84 (m, 15H, ArH) 10.18 (s, 1H, NH).
Ms m/z (%) 446 (M+ +2, 4), 445 (M+ +1, 10), 444 (M+, 22), 443
(12), 298 (6), 286 (7), 103 (6), 91 (14), 77 (96). Anal. calcd.
for C26H20N8 (444.49) C, 70.27, H 4.50, N 25.22. Found: C
70.17, H 4.28, N 25.45 %.
6-Methyl-5-(4-chlorophenylazo)-1,3-diphenyl-1H-pyrazo-
lo[3,4-d]pyrimido[1,6-b][1,2,4]triazine (5i) Yellow solid
(1.87 g, 78 %), mp 280ºC. IR (cm–1): 3314, 1H NMR (DMSO-
d6) 2.40 (s, 3H, CH3), 7.34 (s, 1H, ArH), 7.37-7.70 (m, 10H,
ArH), 8.08 (d, J = 8 Hz, ArH), 8.80 (d, J = 8 Hz, 2H, ArH),
10.26 (s, 1H, NH). Ms m/z (%) 481 (M+ +2, 10), 480 (M+ +1,
14), 479 (M+, 27), 478 (27), 297 (12), 126 (12), 111 (40), 110
(42), 77 (95), 76 (100). Anal. calcd. for C26H19ClN8 (478.94) C,
65.20, H 3.97, N 23.40. Found: C 65.27, H 4.09, N 23.38 %.
5-(3-Chlorophenylazo)-1,3-diphenyl-6-Methyl-1H-pyrazo-
lo[3,4-d]pyrimido[1,6-b][1,2,4]triazine (5j): Yellow solid (2.0 g,
85 %), mp > 340ºC. IR (cm–1): 3350, 1H NMR (DMSO-d6) 2.73
(s, 3H, CH3), 7.51-8.52 (m, 14H, ArH), 8.82 (s, 1H, ArH), 10.16
(s, 1H, NH). Ms m/z (%) 480 (M+ +1, 4), 479 (M+, 3), 478 (9),
327 (26), 326 (68), 287 (23), 286 (19), 153 (14), 127 (25), 111
(22), 103 (21), 91 (12), 77 (100). Anal. calcd. for C26H19ClN8
(478.94) C, 65.20,  H 3.97, N 23.40. Found: C 65.32, H 4.12,
N 23.70 %.
6-Methyl-5-(3-nitrophenylazo)-1,3-diphenyl-1H-pyrazo-
lo[3,4-d] pyrimido[1,6-b][1,2,4]triazine (5k) Orange solid
(2.2 g, 90 %), mp 290ºC. IR (cm–1): 3319, 1H NMR (DMSO-
d6) 2.18 (s, 3H, CH3), 7.44-8.12 (m, 14H, ArH), 8.39 (s, 1H,
ArH), 10.60 (s, 1H, NH). Ms m/z (%) 490 (M+ +1, 3), 489 (M+,
8), 488 (1), 326 (100), 312 (18), 163 (14), 129 (19), 103 (23),
91 (17), 77 (75). Anal. calcd. for C26H19N9O2 (489.49) C, 63.80,
H 3.89, N 25.77. Found: C 63.70, H 4.29, N 25.47 %.
6-Methyl-5-(4-nitrophenylazo)-1,3-diphenyl-1H-pyrazo-
lo[3,4-d]pyrimido[1,6-b][1,2,4]triazine (5l) Yellow solid
(1.98 g, 81 %), mp > 340ºC. IR (cm–1): 3422, 1H NMR (DMSO-
d6) 2.49 (s, 3H, CH3), 7.01 (d, J = 9 Hz, 2H, ArH), 7.41-8.39
(m, 10H, ArH), 8.05 (s, 1H, ArH), 8.81 (d, J = 9 Hz, 2H, ArH),
10.20 (s, 1H, NH). Ms m/z (%) 490 (M+ +1, 10), 489 (M+, 30),
422(36), 287(24), 236(15), 129(31), 123(25), 105(29), 91(25),
81(54), 77(54). Anal. calcd. for C26H19N9O2 (489.49) C, 63.80,
H 3.89, N 25.77. Found: C 63.67, H 3.77, N 25.52 %.
6-Methyl-5-(4-acetylphenylazo)-1,3-diphenyl-1H-pyrazo-
lo[3,4-d] pyrimido[1,6-b][1,2,4]triazine (5m) Yellow solid
(2.07 g, 85 %), mp 235ºC. IR (cm–1): 3338, 1688. 1H NMR
(DMSO-d6) 2.44 (s, 3H, CH3), 2.49 (s, 3H, COCH3) 7.39-7.60
(m, 10H, ArH), 8.02 (s, 1H, ArH), 8.09 (d, J = 8 Hz, 2H, ArH),
8.43 (d, J = 8 Hz, 2H, ArH), 10.82 (s, 1H, NH). Ms m/z (%)
487 (M+ +1, 4), 458 (10), 223 (10), 208 (15), 145 (24), 123 (20),
111 (49), 97 (71), 73 (31). Anal. calcd. for C28H22N8O (486.53)
C, 69.14, H 4.53, N 23.05. Found: C 69.37, H 4.82, N 23.00 %.
5-(4-Ethoxycarbonylphenylazo)-1,3-diphenyl-6-Methyl-1H-
pyrazolo[3,4-d]pyrimido[1,6-b][1,2,4]triazine (5n): Yellow
solid (2.2 g, 86 %), mp > 340ºC. IR (cm–1): 3349, 1685. 1H NMR
(DMSO-d6) 1.06 (t, J = 7 Hz, 3H, CH3), 2.49 (s, 3H, CH3), 4.28
(q, J = 7 Hz, 2H, CH2) 7.40-8.03 (m, 10H, ArH), 8.10 (d, J =
9 Hz, 2H, ArH), 8.57 (s,1H, ArH), 8.82 (d, J = 9 Hz, 2H,  ArH),
10.20 (s, 1H, NH). Ms m/z (%) 517 (M+ +1, 10), 516 (M+, 25),
515 (5), 488 (27), 368 (36), 326 (59), 325 (40), 264 (21), 247
(24), 165 (29), 133 (35), 110 (62), 84 (100). Anal. calcd. for
C29H24N8O2 (516.55) C, 67.44,  H 4.65, N 21.71. Found: C
67.67, H 4.46, N 21.48 %.
Alternate synthesis of 5a:
To solution of 1 (1.56 g, 5 mmole) in pyridine (10 ml)
phenacyl bromide (1.00 g, 5mmole) was added. The mix-
ture was reflexed for 4hrs, cooled and poured onto ice-
cold hydrochloric acid with stirring. The solid precipitate,
so formed, was filtered off, washed with water and finally
crystallized from dioxane to give 9 as dark orange crystals
(1.65 g, 82%).
mp 195ºC. IR (cm–1): 3475, 1H NMR (DMSO-d6) 6.09 (s, 1H,
ArH), 7.33-8.20 (m, 15H, ArH), 8.40 (s, 1H, ArH), 12.40 (s, 1H,
NH). Ms m/z (%) 403 (M+ +1, 10), 402 (M+, 20), 401 (18), 387
(18), 327(4), 298(20), 287 (17), 142 (10), 127 (15), 103(23), 77
(100). Anal. calcd. for C25H18N6 (402.46) C, 74.62,  H 4.48, N
20.90. Found: C, 74.33, H, 4.45, N, 20.99 %.
To a solution of 9 (2.01 g, 5 mmole) in ethanol (40 ml) was
added sodium hydroxide (0.5 g) and the mixture was cooled
in an ice bath at 0-5ºC while being stirred. To the resulting
cold solution was added portionwise a cold solution of the
benzene diazonium chloride, prepared as usual by diazo-
tized aniline (0.5 g, 5 mmole) in hydrochloric acid (6M, 3 ml)
with sodium nitrite (0.35 g, 5 mmole) in water (5 ml), after
all the diazonium salt was added, the mixture was stirred
for further 30 min. while cooling in ice-bath. The solid that
precipitated was filtered off, washed with water, dried and
finally  crystallized from ethanol/DMF to give compound
5a which proved to be identical in all respects (mp., mixed
mp., IR, Ms. and 1HNMR spectra) with the product isolat-
ed above from the reaction of N-phenyl-2-oxo-2-phenyl-
ethanehydrazonoyl chloride 2a with 1. 
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